PELP1 and cancer: Interestingly, engineered clones of BCa cells expressing cytoplasmic PELP1 are tumorigenic in vivo, promote apototic sensitivity changes, and are estrogen-independent, highlighting the role of PELP1 subcellular localization in cancer progression [74].